Splanchnic venous thrombosis may suggest undiagnosed cancer
the ONA take:
According to a new study published in the journal Blood, researchers have found that a blood clot in an abdominal vein may suggest undiagnosed cancer, and these clots may indicate reduced survival in patients with liver and pancreatic cancer.
For the study, researchers analyzed the risk for subsequent cancer diagnosis of 1,191 Danish patients who were diagnosed with abdominal clots and evaluated the survival of those with a splanchnic venous thrombosis (SVT) and cancer versus those without cancer.
Results showed that compared with the general Danish population, patients who developed an SVT were 33 times more likely to be diagnosed with cancer during the first 3 months after SVT diagnosis. In addition, patients with an SVT and liver or pancreatic cancer had a significantly worse 3-month survival compared with those without an SVT.
Researchers also found that patients diagnosed with an SVT were more likely to develop a myeloproliferative neoplasm beyond 12 months after SVT diagnosis.
A blood clot in an abdominal vein may suggest undiagnosed cancer.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Smoking-related Cancer Deaths Highest in Southern United States
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|